Search research articles
Contact Us
Filters
Showing results (81-90 of 91) with videos related to
Page
of 10
Sort By:
Retina (Philadelphia, Pa.)
|
April 27, 2018
DEXAMETHASONE IMPLANT FOR DIABETIC MACULAR EDEMA IN NAIVE COMPARED WITH REFRACTORY EYES: The International Retina Group Real-Life 24-Month Multicenter Study. The IRGREL-DEX Study
Matias Iglicki, Catharina Busch, Dinah Zur, et al.
Scientific Reports
|
February 27, 2021
GRAding of functional and anatomical response to DExamethasone implant in patients with Diabetic Macular Edema: GRADE-DME Study
Patricio J Rodríguez-Valdés, Matus Rehak, Dinah Zur, et al.
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde
|
March 20, 2019
Causative Pathogens of Endophthalmitis after Intravitreal Anti-VEGF Injection: An International Multicenter Study
Catharina Busch, Matias Iglicki, Mali Okada, et al.
Acta Diabetologica
|
May 7, 2018
Shall we stay, or shall we switch? Continued anti-VEGF therapy versus early switch to dexamethasone implant in refractory diabetic macular edema
Catharina Busch, Dinah Zur, Samantha Fraser-Bell, et al.
Acta Ophthalmologica
|
March 3, 2020
Baseline predictors for visual acuity loss during observation in diabetic macular oedema with good baseline visual acuity
Catharina Busch, Mali Okada, Dinah Zur, et al.
Acta Diabetologica
|
March 24, 2019
Real-world outcomes of observation and treatment in diabetic macular edema with very good visual acuity: the OBTAIN study
Catharina Busch, Samantha Fraser-Bell, Dinah Zur, et al.
The British Journal of Ophthalmology
|
June 13, 2018
Long-term visual outcome and its predictors in macular oedema secondary to retinal vein occlusion treated with dexamethasone implant
Catharina Busch, Matus Rehak, Chintan Sarvariya, et al.
Acta Diabetologica
|
September 22, 2019
Real-world outcomes of non-responding diabetic macular edema treated with continued anti-VEGF therapy versus early switch to dexamethasone implant: 2-year results
Catharina Busch, Samantha Fraser-Bell, Matias Iglicki, et al.
Klinische Monatsblatter Fur Augenheilkunde
|
February 6, 2023
Current Practice in the Treatment of Epithelial and Melanocytic Tumours with Interferon-α2b: A Survey of Tertiary Eye Centres in Germany
Jana Jiang, Daniel Böhringer, Claudia Auw-Hädrich, et al.
American Journal of Ophthalmology
|
August 11, 2022
Polypoidal Choroidal Vasculopathy Based on Non-ICGA Criteria in White Patients With Neovascular Age-Related Macular Degeneration
Voraporn Chaikitmongkol, Malgorzata Ozimek, Titipol Srisomboon, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 91) with videos related to
Sort By:
Page
of 10
Retina (Philadelphia, Pa.)
|
April 27, 2018
DEXAMETHASONE IMPLANT FOR DIABETIC MACULAR EDEMA IN NAIVE COMPARED WITH REFRACTORY EYES: The International Retina Group Real-Life 24-Month Multicenter Study. The IRGREL-DEX Study
Matias Iglicki, Catharina Busch, Dinah Zur, et al.
Scientific Reports
|
February 27, 2021
GRAding of functional and anatomical response to DExamethasone implant in patients with Diabetic Macular Edema: GRADE-DME Study
Patricio J Rodríguez-Valdés, Matus Rehak, Dinah Zur, et al.
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde
|
March 20, 2019
Causative Pathogens of Endophthalmitis after Intravitreal Anti-VEGF Injection: An International Multicenter Study
Catharina Busch, Matias Iglicki, Mali Okada, et al.
Acta Diabetologica
|
May 7, 2018
Shall we stay, or shall we switch? Continued anti-VEGF therapy versus early switch to dexamethasone implant in refractory diabetic macular edema
Catharina Busch, Dinah Zur, Samantha Fraser-Bell, et al.
Acta Ophthalmologica
|
March 3, 2020
Baseline predictors for visual acuity loss during observation in diabetic macular oedema with good baseline visual acuity
Catharina Busch, Mali Okada, Dinah Zur, et al.
Acta Diabetologica
|
March 24, 2019
Real-world outcomes of observation and treatment in diabetic macular edema with very good visual acuity: the OBTAIN study
Catharina Busch, Samantha Fraser-Bell, Dinah Zur, et al.
The British Journal of Ophthalmology
|
June 13, 2018
Long-term visual outcome and its predictors in macular oedema secondary to retinal vein occlusion treated with dexamethasone implant
Catharina Busch, Matus Rehak, Chintan Sarvariya, et al.
Acta Diabetologica
|
September 22, 2019
Real-world outcomes of non-responding diabetic macular edema treated with continued anti-VEGF therapy versus early switch to dexamethasone implant: 2-year results
Catharina Busch, Samantha Fraser-Bell, Matias Iglicki, et al.
Klinische Monatsblatter Fur Augenheilkunde
|
February 6, 2023
Current Practice in the Treatment of Epithelial and Melanocytic Tumours with Interferon-α2b: A Survey of Tertiary Eye Centres in Germany
Jana Jiang, Daniel Böhringer, Claudia Auw-Hädrich, et al.
American Journal of Ophthalmology
|
August 11, 2022
Polypoidal Choroidal Vasculopathy Based on Non-ICGA Criteria in White Patients With Neovascular Age-Related Macular Degeneration
Voraporn Chaikitmongkol, Malgorzata Ozimek, Titipol Srisomboon, et al.
Page
of 10